Triple Agonists May Become the New Standard Retatrutides results suggest that future obesity therapies may move toward increasingly sophisticated multi-pathway peptides
GLP-1 injections offer a new approach by tackling two major concerns at oncehigh blood sugar and excess body weight
Its frustrating for many women because they think theyre supposed to feel amazing at this time of the month, and instead they are plagued by headaches, fatigue, bloating, itching, insomnia, irritability and gut issues
Both contain tirzepatide as the active ingredient, but the manufacturing and regulatory pathways differ
The net effect of tirzepatide on bone health likely represents a balance between potential direct skeletal effects of incretin signaling and the mechanical and nutritional challenges of significant weight loss
Ozempic and Rybelsus are approved for type 2 diabetes only